Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 1, 2015
0Patent Application Number
130241740
Date Filed
February 9, 2011
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to amino acid sequences that are directed against TRAIL cell surface receptor 2 (herein also “DR5”), as well as to compounds or constructs thereof, and in particular proteins and polypeptides and nucleotides that encode them (referred to herein in their entirety as “NB agents”) and fragments thereof, and pharmaceutically effective variants thereof, and their use in the diagnosis and treatment of DR5 associated diseases and disorders.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
